BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35116590)

  • 1. E2F1/2/4 mRNA is associated with immune infiltration and are potential biomarkers for the prognosis of human gastric carcinoma.
    Chen Y; Gong W; Dai W; Jiang H; Xu X
    Transl Cancer Res; 2021 Jun; 10(6):2801-2811. PubMed ID: 35116590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-596 down regulates SOX4 expression and is a potential novel biomarker for gastric cancer.
    Chen Y; Gong W; Dai W; Pan Z; Xu X; Jiang H
    Transl Cancer Res; 2020 Feb; 9(2):1294-1302. PubMed ID: 35117475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of E2F Family Members in Human Gastric Cancer.
    Li S; Yang X; Li W; Chen Z
    Front Oncol; 2021; 11():625257. PubMed ID: 34532281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.
    Liao P; Han S; Qu H
    Biomed Res Int; 2020; 2020():6281635. PubMed ID: 33381564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.
    Liu X; Hu C
    Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
    Zhang C; Cui Y; Wang G; Zhao W; Zhao H; Huang X; Zhang M; Li W
    J Healthc Eng; 2021; 2021():5790416. PubMed ID: 34531966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
    Hu D; Meng N; Lou X; Li Z; Teng Y; Tu B; Zou Y; Wang F
    Int J Gen Med; 2021; 14():3593-3609. PubMed ID: 34295182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 9. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
    Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
    Front Oncol; 2020; 10():606735. PubMed ID: 33604289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
    Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
    World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis.
    Li M; Zhou C
    Transl Cancer Res; 2021 Jun; 10(6):2663-2677. PubMed ID: 35116579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer.
    Wang J; Liu D; Xie Y
    Front Oncol; 2023; 13():1142017. PubMed ID: 37469414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 14. EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer.
    Zheng P; Liu X; Li H; Gao L; Yu Y; Wang N; Chen H
    Front Genet; 2021; 12():796592. PubMed ID: 35126464
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer.
    Huang J; Chen W; Jie Z; Jiang M
    Front Oncol; 2022; 12():820568. PubMed ID: 35237521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer.
    Fang ZX; Hou YY; Wu Z; Wu BX; Deng Y; Wu HT; Liu J
    World J Clin Oncol; 2023 Aug; 14(8):297-310. PubMed ID: 37700807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
    Wang M; Li C; Liu Y; Wang Z
    Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
    Zhu H; Wang G; Zhu H; Xu A
    J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
    [No Abstract]   [Full Text] [Related]  

  • 20. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
    Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
    Front Immunol; 2022; 13():922138. PubMed ID: 36090985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.